Cargando…
Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107680/ https://www.ncbi.nlm.nih.gov/pubmed/33981612 http://dx.doi.org/10.3389/fonc.2021.663679 |
_version_ | 1783689994192289792 |
---|---|
author | Wang, Yichun Ye, Dongmei Kang, Mei Zhu, Liyang Yang, Mingwei Jiang, Jun Xia, Wanli Kang, Ningning Chen, Xiangcun Wang, Jie Wang, Fan |
author_facet | Wang, Yichun Ye, Dongmei Kang, Mei Zhu, Liyang Yang, Mingwei Jiang, Jun Xia, Wanli Kang, Ningning Chen, Xiangcun Wang, Jie Wang, Fan |
author_sort | Wang, Yichun |
collection | PubMed |
description | BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the recurrent lymph nodes in the cervical and upper mediastinal regions and explore a reasonable CTVnd for PORT in TESCC. METHODS: We retrospectively reviewed patients in our hospital with first cervical and/or upper mediastinal lymph node recurrence (LNR) after upfront esophagectomy. All of these recurrent lymph nodes were plotted on template computed tomography (CT) images with reference to surrounding structures. The recurrence frequency at different stations was investigated and the anatomic distribution of recurrent lymph nodes was analyzed. RESULTS: A total of 119 patients with 215 recurrent lymph nodes were identified. There were 47 (39.5%) patients with cervical LNR and 102 (85.7%) patients with upper mediastinal LNR. The high-risk regions were station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. LNR in the external group of station 104L/R was not common, and LNR was not found in the narrow spaces where the trachea was in close contact with the innominate artery, aortic arch and mediastinal pleura. LNR below the level of the cephalic margin of the superior vena cava was also not common for upper TESCC. CONCLUSIONS: The CTVnd of PORT in the cervical and upper mediastinal regions should cover station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. Based on our results, we proposed a useful atlas for guiding the delineation of CTVnd in TESCC. |
format | Online Article Text |
id | pubmed-8107680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81076802021-05-11 Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma Wang, Yichun Ye, Dongmei Kang, Mei Zhu, Liyang Yang, Mingwei Jiang, Jun Xia, Wanli Kang, Ningning Chen, Xiangcun Wang, Jie Wang, Fan Front Oncol Oncology BACKGROUND: The lower neck and upper mediastinum are the major regions for postoperative radiotherapy (PORT) in thoracic esophageal squamous cell carcinoma (TESCC). However, there is no uniform standard regarding the delineation of nodal clinical target volume (CTVnd). This study aimed to map the recurrent lymph nodes in the cervical and upper mediastinal regions and explore a reasonable CTVnd for PORT in TESCC. METHODS: We retrospectively reviewed patients in our hospital with first cervical and/or upper mediastinal lymph node recurrence (LNR) after upfront esophagectomy. All of these recurrent lymph nodes were plotted on template computed tomography (CT) images with reference to surrounding structures. The recurrence frequency at different stations was investigated and the anatomic distribution of recurrent lymph nodes was analyzed. RESULTS: A total of 119 patients with 215 recurrent lymph nodes were identified. There were 47 (39.5%) patients with cervical LNR and 102 (85.7%) patients with upper mediastinal LNR. The high-risk regions were station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. LNR in the external group of station 104L/R was not common, and LNR was not found in the narrow spaces where the trachea was in close contact with the innominate artery, aortic arch and mediastinal pleura. LNR below the level of the cephalic margin of the superior vena cava was also not common for upper TESCC. CONCLUSIONS: The CTVnd of PORT in the cervical and upper mediastinal regions should cover station 101L/R, station 104L/R, station 106recL/R, station 105 and station 106pre for upper TESCC and station 104L/R, station 106recL/R, station 105, station 106pre and station 106tbL for middle and lower TESCCs. Based on our results, we proposed a useful atlas for guiding the delineation of CTVnd in TESCC. Frontiers Media S.A. 2021-04-26 /pmc/articles/PMC8107680/ /pubmed/33981612 http://dx.doi.org/10.3389/fonc.2021.663679 Text en Copyright © 2021 Wang, Ye, Kang, Zhu, Yang, Jiang, Xia, Kang, Chen, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Yichun Ye, Dongmei Kang, Mei Zhu, Liyang Yang, Mingwei Jiang, Jun Xia, Wanli Kang, Ningning Chen, Xiangcun Wang, Jie Wang, Fan Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title | Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title_full | Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title_fullStr | Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title_full_unstemmed | Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title_short | Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma |
title_sort | mapping of cervical and upper mediastinal lymph node recurrence for guiding clinical target delineation of postoperative radiotherapy in thoracic esophageal squamous cell carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107680/ https://www.ncbi.nlm.nih.gov/pubmed/33981612 http://dx.doi.org/10.3389/fonc.2021.663679 |
work_keys_str_mv | AT wangyichun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT yedongmei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT kangmei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT zhuliyang mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT yangmingwei mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT jiangjun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT xiawanli mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT kangningning mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT chenxiangcun mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT wangjie mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma AT wangfan mappingofcervicalanduppermediastinallymphnoderecurrenceforguidingclinicaltargetdelineationofpostoperativeradiotherapyinthoracicesophagealsquamouscellcarcinoma |